Oliver Ritter
Senior physician
Department of Internal Medicine I, Cardiology
The Julius Maximilian University of Wurzburg
Germany
Biography
Education and Training 1988–1994 Medical studies at Ruprecht-Karls-Universität Heidelberg and the Emory University in Georgia, USA 1992–1994 Doctoral theses; Institute of Physiology and Pathophysiology University of Heidelberg, Prof. Dr. I. Morano 1994 Medical studies at University of Texas, Texas Heart Institute (Houston, USA) Positions and Employment 1995/96 Clinical and research assistant at the Max Delbruck Center for molecular medicine, Franz Volhard Klinik des Virchow-Klinikums der Humboldt Universität zu Berlin (Prof. R. Dietz) 1997–1999 2.5 years research fellow at the Max Delbruck Center for molecular medicine, Berlin group of Prof. I. Morano (Head: Prof. D. Ganten) 1999–2002 Clinical and research assistant in the department of Cardiology at the University Hospital Würzburg, group of Prof. L. Neyses (Head: Prof. Dr. G. Ertl) 2002 Consultant for internal medicine 2004 Consultant for cardiology 2005 State doctorate for internal medicine 2005 Chief resident cardiac electrophysiology Medizinische Klinik I der Universität Würzburg 2005 Head of the molecular cardiology laboratory 2006 Senior physician for cardiology and electrophysiology Medizinische Klinik I der Universität Würzburg 2007 Head of the electrophysiology department, Department of Internal Medicine I, University Hospital of Würzburg 2010 Adjunct professor 2012 Head of emergency room and intensive care unit, Department of Internal Medicine I, University Hospital of Würzburg
Research Interest
 Main interests Development of Chagas Cardiomyopathy, Influence of Nitric oxide synthases and NO, interventional cardiology, interventional electrophysiology, device implantation (SM, ISD, CRT), intensive care.  Ongoing research support • The calcineurin signalling pathway • CALPORTIN Pharmaceuticals • Chagas cardiomyopathy • nNOS-CAPON interaction in a model of transgenic conditional myocardium-specific overexpression • nuclear transport in heart failure as mechanism of signal transduction • nuclear calcium in heart failure as mechanism of signal transduction • development of pacing leads for magnetic resonance imaging • invasive electrophysiology and ablations in magnetic resonance environment
Publications
-
The CCR4-NOT complex contributes to repression of Major Histocompatibility Complex class II transcription. Shock efficacy of single and dual coil electrodes-new insights from the NORDIC ICD Trial. Smoking habits in French farmers: a cross-sectional study. Divergent endothelial function but similar platelet microvesicle responses following eccentric and concentric cycling at a similar aerobic power output. TRPC4α and TRPC4β Similarly Affect Neonatal Cardiomyocyte Survival during Chronic GPCR Stimulation. Similar substrate oxidation rates in concentric and eccentric cycling matched for aerobic power output. Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy.
